Compare Equity Development Investment Tbk. (GSMF) vs Indofarma Tbk. (INAF) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Equity Development Investment Tbk. vs Indofarma Tbk. — how do they compare? Equity Development Investment Tbk. trades at Rp106 (market cap 1.92T, 294.19M 24h volume), while Indofarma Tbk. trades at Rp126 (market cap 390.51B). The key difference: Equity Development Investment Tbk. is far larger — about 4.9× Indofarma Tbk.'s market cap. Which is the better fit depends on your goals.
| GSMF | INAF | |
|---|---|---|
Market Cap | 1.92T | 390.51B |
Volume | 294.19M | — |
Lot | 2.94M | — |
Turnover | 36.95B | — |
Average Price | 125.58 | — |
Value | 36.95B | — |
Indicative Equilibrium Price | 106 | — |
Indicative Equilibrium Volume | 8.47K | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Equity Development Investment Tbk.
PT Equity Development Investment Tbk (the “Company”) was established in Jakarta under the name of PT Gajah Surya Arta Leasing on November 1, 1982 based on the Notarial Deed of Didi Sudjadi, S.H., No. 1, as amended by deed No. 30 dated March 6, 1985 of the same notary. The Company changed its name to be PT BDNI Capital Corporation Tbk. On February 7, 2001, it changed the named again to be PT GT Investama Kapital, Tbk.
Read more on GSMF →About Indofarma Tbk.
PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.
Read more on INAF →
